Healthcare provider profile · identity verified

Sandhya Misra, M.D.

Hospice and Palliative Care · DETROIT, MI · NPI 1205066941

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	271	70
Eliquis	Apixaban	256	33
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	171	31
Gabapentin	Gabapentin	129	29
Levothyroxine Sodium	Levothyroxine Sodium	118	24
Furosemide	Furosemide	117	30
Metoprolol Tartrate	Metoprolol Tartrate	115	32
Quetiapine Fumarate	Quetiapine Fumarate	113	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	111	18
Pantoprazole Sodium	Pantoprazole Sodium	102	31
Tamsulosin Hcl	Tamsulosin Hcl	99	25
Midodrine Hcl	Midodrine Hcl	94	23
Oxycodone Hcl	Oxycodone Hcl	71	15
Simvastatin	Simvastatin	63	suppressed
Levofloxacin	Levofloxacin	62	23
Amlodipine Besylate	Amlodipine Besylate	60	20
Metformin Hcl	Metformin Hcl	60	suppressed
Sertraline Hcl	Sertraline Hcl	56	16
Januvia	Sitagliptin Phosphate	53	suppressed
Prednisone	Prednisone	50	19
Duloxetine Hcl	Duloxetine Hcl	49	11
Levetiracetam	Levetiracetam	49	suppressed
Mirtazapine	Mirtazapine	49	12
Spironolactone	Spironolactone	48	suppressed
Bumetanide	Bumetanide	46	15
Risperidone	Risperidone	46	suppressed
Carvedilol	Carvedilol	44	11
Ceftriaxone	Ceftriaxone Sodium	44	22
Hydralazine Hcl	Hydralazine Hcl	43	15
Nifedipine Er	Nifedipine	42	suppressed
Trazodone Hcl	Trazodone Hcl	42	14
Insulin Lispro Kwikpen U-100	Insulin Lispro	40	11
Nystatin	Nystatin	40	18
Potassium Chloride	Potassium Chloride	40	12
Torsemide	Torsemide	40	suppressed
Ertapenem	Ertapenem Sodium	37	13
Lactulose	Lactulose	37	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	22
Albuterol Sulfate	Albuterol Sulfate	36	16
Lisinopril	Lisinopril	36	11
Xarelto	Rivaroxaban	36	suppressed
Lorazepam	Lorazepam	35	18
Oxybutynin Chloride	Oxybutynin Chloride	35	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Cephalexin	Cephalexin	34	20
Divalproex Sodium	Divalproex Sodium	34	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	33	21
Omeprazole	Omeprazole	32	20
Myrbetriq	Mirabegron	31	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	30	suppressed
Amiodarone Hcl	Amiodarone Hcl	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Famotidine	Famotidine	29	11
Lidocaine Hcl	Lidocaine Hcl	29	18
Allopurinol	Allopurinol	28	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	28	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	11
Baclofen	Baclofen	27	suppressed
Metoprolol Succinate	Metoprolol Succinate	27	11
Procrit	Epoetin Alfa	26	suppressed
Alprazolam	Alprazolam	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	12
Donepezil Hcl	Donepezil Hcl	25	suppressed
Labetalol Hcl	Labetalol Hcl	25	suppressed
Linezolid	Linezolid	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	14
Rosuvastatin Calcium	Rosuvastatin Calcium	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	12
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	23	suppressed
Losartan Potassium	Losartan Potassium	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	21	20
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	21	12
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Constulose	Lactulose	20	suppressed
Galantamine Hbr	Galantamine Hbr	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Digoxin	Digoxin	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Sodium Chloride	0.9 % Sodium Chloride	18	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	17	11
Lansoprazole	Lansoprazole	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Ramelteon	Ramelteon	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Azithromycin	Azithromycin	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Primidone	Primidone	16	suppressed
Scopolamine	Scopolamine	16	suppressed
Ursodiol	Ursodiol	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Morphine Sulfate	Morphine Sulfate	15	11
Oxycontin	Oxycodone Hcl	15	suppressed
Phenobarbital	Phenobarbital	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Temazepam	Temazepam	15	suppressed
Veltassa	Patiromer Calcium Sorbitex	15	suppressed
Finasteride	Finasteride	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Budesonide	Budesonide	12	suppressed
Calcitriol	Calcitriol	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Enulose	Lactulose	12	suppressed
Topiramate	Topiramate	12	suppressed
Asenapine Maleate	Asenapine Maleate	11	suppressed
Clopidogrel	Clopidogrel Bisulfate	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Liothyronine Sodium	Liothyronine Sodium	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error